Latest Articles
The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 receptor agonists reduce endometrial cancer risk - 2 Minute Medicine
The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 …
Published: Feb. 11, 2026, 6:31 p.m.
The Intricacy and Importance of Treating Inoperable Endometrial Cancer - CancerNetwork
The Intricacy and Importance of Treating Inoperable Endometrial Cancer CancerNetwork
Published: Feb. 11, 2026, 6:02 p.m.
Research sheds light on key drivers of endometrial cancer - The National Tribune
Research sheds light on key drivers of endometrial cancer The National Tribune
Published: Feb. 11, 2026, 2:10 p.m.
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb - openPR.com
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb openPR.com
Published: Feb. 11, 2026, 12:24 p.m.
Dual role of the endometrial microbiome-immune axis: From endometrial | IJWH - Dove Medical Press
Dual role of the endometrial microbiome-immune axis: From endometrial | IJWH Dove Medical Press
Published: Feb. 11, 2026, 9:02 a.m.
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk - Medscape
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk Medscape
Published: Feb. 11, 2026, 8:49 a.m.
MSK Endometrial Cancer e-Tumor Board - Medscape
MSK Endometrial Cancer e-Tumor Board Medscape
Published: Feb. 10, 2026, 11:06 p.m.
Why is Inoperable Endometrial Cancer Relevant at the 2026 ACRO Summit? - CancerNetwork
Why is Inoperable Endometrial Cancer Relevant at the 2026 ACRO Summit? CancerNetwork
Published: Feb. 10, 2026, 8:43 p.m.
AstraZeneca Imfinzi Approved in India for Endometrial Cancer - Rediff MoneyWiz
AstraZeneca Imfinzi Approved in India for Endometrial Cancer Rediff MoneyWiz
Published: Feb. 10, 2026, 8:42 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer - Express Pharma
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer Express Pharma
Published: Feb. 10, 2026, 6:40 a.m.
Link copied to clipboard!